Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 10, 2025Jurnal Farmasi Sains dan PraktisOpen Access

Study of Adverse Drug Reactions of Linezolid in Drug Resistant Tuberculosis Patients

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRinto SusiloESElza SundhaniISIndah Setyaningsih

Discussion

Loading...

Member takes

Overview

Observational analysis revealed a 32.6% incidence of Linezolid adverse drug reactions in DR TB patients, indicating a need for monitoring and tailored therapies.

Key Points

  • The incidence of adverse drug reactions (ADRs) related to linezolid was found in 70 out of 215 drug-resistant tuberculosis patients.
  • Hematological disorders were reported as the most common form of ADRs, representing 89% of all cases observed.
  • The study employed a retrospective cross-sectional design at two hospitals to assess ADRs related to linezolid treatment.
  • Personalized monitoring of linezolid blood levels is crucial for minimizing severe ADRs and optimizing therapy outcomes.

Cite This Study

Susilo et al. (2025) studied this question.

synapsesocial.com/papers/68e861a57ef2f04ca37e4707https://doi.org/10.31603/pharmacy.v11i2.12472
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1P59 Linezolid in short- term regimens for drug-resistant TB: balancing efficacy and toxicity2025
  2. 2Prevalence and factors associated with Haematological side effects in MDR/RR-TB Patients on Linezolid-Based Regimens in Uganda: A Multicentre Retrospective Study2025
  3. 3Adverse drug reactions to the nine-month all-oral and 18-month regimens for multidrug-resistant tuberculosis in Indonesia2025
  4. 4Study of adverse drug reactions (ADR’S) requiring change in anti-tubercular regimen in multi-drug resistant tuberculosis (MDR-TB) patients in a tertiary healthcare centre2025
  5. 5Patterns of adverse drug reactions and treatment outcomes in drug-resistant tuberculosis: A retrospective study from a tertiary care hospital in Delhi2025